BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5314108)

  • 21. [The immunoglobulins in ankylosing spondylitis].
    Kriegel W; Burger R; Kapp W; Alexopulos J
    Verh Dtsch Ges Rheumatol; 1969; 1():206-11. PubMed ID: 5314829
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serological studies on chronic rheumatoid arthritis].
    Matsutani T
    Ryumachi; 1974 Mar; 14(1):22-42. PubMed ID: 4612751
    [No Abstract]   [Full Text] [Related]  

  • 23. [Plasma exchange in rheumatoid arthritis and systemic lupus erythematosus using the new Y-S sac system].
    Shiokawa J
    Ter Arkh; 1982; 54(6):49-54. PubMed ID: 7112419
    [No Abstract]   [Full Text] [Related]  

  • 24. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
    Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
    Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Systemic lupus erythematosus and drug allergy].
    Filip V; Capşa D
    Med Interna (Bucur); 1967 Dec; 19(12):1465-7. PubMed ID: 4233879
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical expression of systemic lupus erythematosus with anti-U1-RNP and anti-Sm antibodies].
    López-Longo FJ; González Fernández CM; Rodríguez Mahou M; Grau Simó R; Monteagudo Sáez I; Meno García AC; Carreño Pérez L
    Rev Clin Esp; 1997 May; 197(5):329-35. PubMed ID: 9280966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of D-penicillamine on the latex fixation test, hemagglutination test and streptococci-L-agglutination in vitro].
    Keil E; Schütz M; Tanner E; Seidel K
    Z Gesamte Inn Med; 1971 Jan; 26(2):83-5. PubMed ID: 5314856
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on allophlogisty using the lipopolysaccharide skin test. 1. The changed inflammation susceptibility in acute and chronic inflammatory diseases].
    Hiemeyer V; Feyen H
    Med Klin; 1968 Mar; 63(11):422-4. PubMed ID: 5722515
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased antibodies to IgG fragments: correlation with infection due to gram-positive bacteria.
    Waller M; Duma RJ
    J Infect Dis; 1972 Jan; 125(1):45-53. PubMed ID: 4621502
    [No Abstract]   [Full Text] [Related]  

  • 31. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis.
    Vogt B; Führnrohr B; Müller R; Sheriff A
    Autoimmunity; 2007 Jun; 40(4):295-8. PubMed ID: 17516213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-globulins and circulating complexes in early rheumatoid arthritis.
    Hay FC; Young A; Jones MG; Nineham LJ; Male DK; Roitt IM
    Clin Exp Immunol; 1983 Dec; 54(3):723-30. PubMed ID: 6606514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune deposits in the skin of patients with rheumatoid arthritis.
    McGill PE; Brougham PA; Tulloch J
    J Rheumatol; 1984 Aug; 11(4):454-6. PubMed ID: 6384506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunological reactions to connective tissue antigens in rheumatoid arthritis, systemic scleroderma and systemic lupus erythematosus].
    Abdeeva ZhI; Zakharova MM; Rassokhina II; Trofimova TM; Samoĭlova SI
    Ter Arkh; 1980; 52(11):122-6. PubMed ID: 7466639
    [No Abstract]   [Full Text] [Related]  

  • 35. [The significance of immunologic tests in the diagnosis and differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis].
    Guceva B; Grlickov M; Marina N; Calovski J; Cakalaroska D; Pusevski A
    Reumatizam; 1980; 27(1):1-4. PubMed ID: 6156480
    [No Abstract]   [Full Text] [Related]  

  • 36. [Gm properties in rheumatoid diseases with special reference to chronic progressive polyarthritis. II. Anti-Gm factors n rheumatoid diseases].
    Neumann W; Barthel E; Tanner E; Seidel K
    Z Gesamte Inn Med; 1970 Jun; 25(11):500-5. PubMed ID: 5523394
    [No Abstract]   [Full Text] [Related]  

  • 37. Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disorders.
    Clofent-Sanchez G; Laroche-Trainean J; Lucas S; Rispal P; Pellegrin JL; Nurden P; Nurden A
    Hum Antibodies; 1997; 8(2):50-9. PubMed ID: 9289388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinico-immunological characteristics of rheumatoid arthritis and systemic lupus erythematosus].
    Mikunis RI; Kozlova TV
    Ter Arkh; 1983; 55(7):46-9. PubMed ID: 6623383
    [No Abstract]   [Full Text] [Related]  

  • 39. Arthralgia-purpura-weakness-cryoglobulinemia.
    Lapes MJ; Davis JS
    Arch Intern Med; 1970 Aug; 126(2):287-9. PubMed ID: 4194228
    [No Abstract]   [Full Text] [Related]  

  • 40. [Collagen-like protein (CLP) and collagen antbodies in chronic polyarthritis].
    Kreigel W; Langness U; Jahn P; Müller W
    Z Rheumaforsch; 1970; 29(5):173-8. PubMed ID: 5314153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.